FDA issues priority vouchers for psychedelics developers Compass Pathways, Usona Institute, and Transcend Therapeutics
Plus: Trump withdraws nomination of Casey Means for Surgeon General. Will Texas ban in-home ketamine? And what is 2C-B?
External link. We are not responsible for the content.
Read more ↗More From The Microdose (Berkeley)
The poster child for psychedelic mushrooms is named after a country that doesn’t use it
On the history of Psilocybe cubensis and Cuba
An Amanita mushroom poisoning outbreak in California; A case report testing psilocybin for advanced Alzheimer’s disease
Plus: Scientists assess risk of psychedelic-induced mania; and the close of this season’s psychedelic legislation push
Dispatch from The Netherlands Part 2
Reporting from the Interdisciplinary Conference on Psychedelic Research
Latest News
New Series Asks Maestros About Ayahuasca’s Globalization
PLUS Psychedelics and sports, late-stage capitalism, and coming out of the drug use closet. [...] Read More... The po...
The Psychedelic Retreat Bubble
This week’s Sunday Insider: Psychedelic retreats are booming.
Out of This World: Why AI Belongs Beside the Therapist
Safar founder Sabba Nazhand watched the mental health system fail his mother, then himself. He argues AI's place is b...
When Do Psychedelics Go Too Far?
Welcome to The Psychedelic Blog.
Do Psychedelics Actually Improve Athletic Performance?
Athletes say they feel stronger, calmer, and faster. Does the data back this up? [...] Read More... The post Do Psych...
Shroomski Melt
Shroomski Magazine drops their latest issue at their annual Summer Melt with cover art done by the one and only, Luke...